AptaBio Therapeutics Inc. Stock

Equities

A293780

KR7293780003

Biotechnology & Medical Research

End-of-day quote Korea S.E. 18:00:00 2024-04-25 EDT 5-day change 1st Jan Change
5,650 KRW -2.42% Intraday chart for AptaBio Therapeutics Inc. -2.25% -37.57%

Financials

Sales 2022 48.35M 35.15K 48.01K Sales 2023 324M 235K 322K Capitalization 202B 147M 200M
Net income 2022 -10.56B -7.68M -10.49M Net income 2023 -19.1B -13.88M -18.96M EV / Sales 2022 4,567 x
Net cash position 2022 16.65B 12.1M 16.53M Net cash position 2023 38.95B 28.32M 38.68M EV / Sales 2023 503 x
P/E ratio 2022
-22.5 x
P/E ratio 2023
-10.7 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 65.49%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.42%
1 week-2.25%
Current month-19.40%
1 month-12.81%
3 months-22.18%
6 months-26.24%
Current year-37.57%
More quotes
1 week
5 630.00
Extreme 5630
6 120.00
1 month
5 600.00
Extreme 5600
7 530.00
Current year
4 935.00
Extreme 4935
9 520.00
1 year
4 935.00
Extreme 4935
13 330.00
3 years
4 935.00
Extreme 4935
62 100.00
5 years
4 935.00
Extreme 4935
62 100.00
10 years
4 935.00
Extreme 4935
62 100.00
More quotes
Managers TitleAgeSince
Founder 55 09-07-23
President 65 -
Director of Finance/CFO 54 -
Members of the board TitleAgeSince
Founder 55 09-07-23
Director/Board Member 62 -
President 65 -
More insiders
Date Price Change Volume
24-04-26 5,650 -2.42% 28,078
24-04-25 5,790 -1.53% 15,779
24-04-24 5,880 +0.51% 24,743
24-04-23 5,850 -0.85% 23,659
24-04-22 5,900 +2.08% 31,653

End-of-day quote Korea S.E., April 25, 2024

More quotes
Aptabio Therapeutics Inc. is a Korea-based company that researches and develops new drugs. The Company is developing anti-cancer drugs, drugs for inflammatory and fibrotic diseases and diabetic complications drugs, among others.
More about the company
  1. Stock Market
  2. Equities
  3. A293780 Stock